23andMe Releases New FDA-Cleared Genetic Report on Simvastatin

23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin In an exciting development, 23andMe has become the first and only direct-to-consumer product to offer a suite of FDA-authorized pharmacogenetics reports, providing valuable medication insights. One such report focuses on simvastatin, a widely prescribed lipid-lowering statin. Genetics can significantly i..